$0.71-0.03 (-4.05%)
Scinai Immunotherapeutics Ltd., a biopharmaceutical company, focuses on developing, manufacturing, and commercializing inflammation and immunology biological products for the treatment of infectious and autoimmune diseases in Israel.
Scinai Immunotherapeutics Ltd. in the Healthcare sector is trading at $0.71. The stock is currently near its 52-week low of $0.46, remaining 36.0% below its 200-day moving average. Technical signals show neutral RSI of 58 and bullish MACD crossover, explaining why SCNI maintains its current current market pressure. The Whystock Score of 30/100 signals elevated caution as indicators diverge.
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Scinai Immunotherapeutics Ltd., a biopharmaceutical company, focuses on developing, manufacturing, and commercializing inflammation and immunology biological products for the treatment of infectious and autoimmune diseases in Israel. It develops nano...